In plasma fractionation process protein products are fractionated from human plasma for the prevention, and treatment of life-threatening conditions such as congenital deficiencies, immunologic disorders, and others.
Plasma Fractionation Market Size and Growth Rate:
According to the Research Report, the Global Plasma Fractionation Market Size has valued USD 18,073 Million in 2017 and is projected to grow at a CAGR of 6.5% during the forecast period.
Plasma Fractionation Market - Drivers and Growth:
Rising participation of market players is one of the key factors driving the plasma fractionation market. For instance, in 2018, Grifols acquired 24 plasma donation centres in the United States operated by Biotest Pharmaceuticals Corp. for USD 286 million. With this acquisition, Grifols now owns 249 plasma donation centres to increase its supply of plasma proteins used for therapeutic purposes.
Plasma Fractionation Market - Regional Presence:
Various other factors such as increasing geriatric population, technological advancements, emerging markets in APAC and RoW, rising plasma collection, and increasing prevalence of respiratory and autoimmune disorders are also expected to propel the growth of the market.
The Americas dominated the global market for plasma fractionation owing to the presence of major market players and increasing prevalence of immunodeficiency disorders within the region. According to the 2018 study published in the Allergy, Asthma & Clinical Immunology journal, the estimated overall prevalence of immunoglobulin A (IgA) deficiency in the US was approximately 1 in 300 to 1 in 500 persons.
In 2017, it was estimated that Europe stood second in the global plasma fractionation market. This can be attributed to the increasing technological advancements and rising R&D investments.
The Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the Australian Institute of Health and Welfare, from 2015 to 2016, the total health expenditure was USD 181 billion. Out of this, USD 69 billion was spent on hospitals, which is a real increase of USD 2 billion from the previous year. During the same years, non-government sources spent USD 55.8 billion on health.
Prominent Companies leading the Global Plasma Fractionation Market:
- Bio Products Laboratory (BPL)
- Biotest AG
- China Biologic Products Holdings, Inc.
- CSL Limited
- Green Cross Corporation
- Grifols, S.A.
- Japan Blood Products Organization
- Kedrion S.p.A
- LFB group
- Octapharma AG
- Sanquin
- Shanghai RAAS
- Shire
Plasma Fractionation Market Detailed Segmentation:
Plasma Fractionation Market - By Product:
- Immunoglobulin
- Coagulation Factor Concentrates
- Albumin
- Protease Inhibitors
Plasma Fractionation Market - By Application:
- Immunology
- Neurology
- Haematology
- Critical Care
- Pulmonology
- Rheumatology
- Hemato-Oncology
- Others
Plasma Fractionation Market - By End User:
- Hospitals & Clinics
- Clinical Research Laboratories
- Academic Institutes
- Others
Plasma Fractionation Market - By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Intended Audience for Plasma Fractionation Market:
- Government and Private Laboratories
- Research and Development (R&D) companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Opportunities
5.4 Pricing Analysis
Chapter 6. Global Plasma Fractionation Market, By Product
6.1 Introduction
6.2 Immunoglobulin
6.2.1 Intravenous Immunoglobulin (IVIG)
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.2.2 Subcutaneous Immunoglobulin (SCIG)
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.2.3 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3 Coagulation Factor Concentrates
6.3.1 Factor VIII
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3.2 Factor IX
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3.3 Von Willebrand Factor
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3.4 Prothrombin Complex Concentrate
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3.5 Fibrinogen Concentrates
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3.6 Factor XIII
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.4 Albumin
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.5 Protease Inhibitors
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.6 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 7. Global Plasma Fractionation Market, By Application
7.1 Introduction
7.2 Immunology
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.3 Neurology
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.4 Hematology
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.5 Critical Care
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.6 Pulmonology
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.7 Rheumatology
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.8 Hemato-Oncology
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.9 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 7. Global Plasma Fractionation Market, By End User
7.1 Introduction
7.2 Hospitals & Clinics
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.3 Clinical Research Laboratories
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.4 Academic Institutes
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.5 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 8. Global Plasma Fractionation Market, By Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest Of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest Of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Bio Products Laboratory (BPL)
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Biotest AG
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 China Biologic Products Holdings, Inc.
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 CSL Limited
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Green Cross Corporation
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial Overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Grifols, S.A.
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Japan Blood Products Organization
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Kedrion S.P.A
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 LFB Group
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 Octapharma AG
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 Sanquin
10.11.1 Overview
10.11.2 Product Overview
10.11.3 Financials
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.12 Shanghai RAAS
10.12.1 Overview
10.12.2 Product Overview
10.12.3 Financials
10.12.4 Key Developments
10.12.5 SWOT Analysis
10.13 Shire
10.13.1 Overview
10.13.2 Product Overview
10.13.3 Financials
10.13.4 Key Developments
10.13.5 SWOT Analysis
10.14 TP Orthodontics
10.14.1 Overview
10.14.2 Product Overview
10.14.3 Financials
10.14.4 Key Developments
10.14.5 SWOT Analysis
10.15 Ultradent Products
10.15.1 Overview
10.15.2 Product Overview
10.15.3 Financials
10.15.4 Key Developments
10.15.5 SWOT Analysis
10.16 Other
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs Of The Market
11.2 Key Companies To Watch
11.3 Predictionsfor The Global Plasma Fractionation Market
Chapter 12 Appendix
LIST OF TABLES
Table 1 Plasma Fractionation Market Synopsis, 2018–2023
Table 2 Plasma Fractionation Market Estimates And Forecast, 2018–2023 (USD Million)
Table 3 Global Plasma Fractionation Market, By Region, 2018–2023 (USD Million)
Table 4 Global Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 5 Global Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 6 Global Plasma Fractionation Market, End User, 2018–2023 (USD Million)
Table 7 North America: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 8 North America: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 9 North America: Plasma Fractionation Market, End User, 2018–2023 (USDMillion)
Table 10 US: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 11 US: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 12 US: Plasma Fractionation Market, End User, 2018–2023 (USD Million)
Table 13 Canada:Plasma Fractionation Market,By Product, 2018–2023 (USD Million)
Table 14 Canada: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 15 Canada: Plasma Fractionation Market, End User, 2018–2023 (USDMillion)
Table 16 South America: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 17 South America: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 18 South America: Plasma Fractionation Market, End User, 2018–2023 (USDMillion)
Table 19 Europe: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 20 Europe: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 21 Europe: Plasma Fractionation Market, End User, 2018–2023 (USD Million)
Table 22 Western Europe: Plasma Fractionation Market, By Product, 2018–2023 (USDMillion)
Table 23 Western Europe: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 24 Western Europe: Plasma Fractionation Market, By End User, 2018–2023(USD Million)
Table 25 Eastern Europe: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 26 Eastern Europe: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 27 Eastern Europe: Plasma Fractionation Market, End User, 2018–2023(USD Million)
Table 28 Asia-Pacific: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 29 Asia-Pacific: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 30 Asia-Pacific: Plasma Fractionation Market, End User, 2018–2023 (USD Million)
Table 31 Middle East & Africa: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 32 Middle East & Africa: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 33 Middle East & Africa: Plasma Fractionation Market, End User, 2018–2023(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Plasma Fractionation Market
Figure 3 Market Dynamics For Global Plasma Fractionation Market
Figure 4 Plasma Fractionation Market Share, By Product, 2017
Figure 5 Plasma Fractionation Market Share, By Application, 2017
Figure 6 Plasma Fractionation Market Share, End User, 2017
Figure 7 Plasma Fractionation Market Share, By Region, 2017
Figure 8 North America: Plasma Fractionation Market Share, By Country, 2017
Figure 9 Europe: Plasma Fractionation Market Share, By Country, 2017
Figure 10 Asia-Pacific: Plasma Fractionation Market Share, By Country, 2017
Figure 11 Middle East & Africa: Plasma Fractionation Market Share, By Region, 2017
Figure 12 Plasma Fractionation Market: Company Share Analysis, 2017 (%)
Figure 13 Bio Products Laboratory (BPL): Key Financials
Figure 14 Bio Products Laboratory (BPL): Segmental Revenue
Figure 15 Bio Products Laboratory (BPL): Geographical Revenue
Figure 16 Biotest AG: Key Financials
Figure 17 Biotest AG: Segmental Revenue
Figure 18 Biotest AG: Geographical Revenue
Figure 19 China Biologic Products Holdings, Inc.: Key Financials
Figure 20 China Biologic Products Holdings, Inc.: Segmental Revenue
Figure 21 China Biologic Products Holdings, Inc.: Geographical Revenue
Figure 22 CSL Limited: Key Financials
Figure 23 CSL Limited: Segmental Revenue
Figure 24 CSL Limited: Geographical Revenue
Figure 25 Green Cross Corporation: Key Financials
Figure 26 Green Cross Corporation: Segmental Revenue
Figure 27 Green Cross Corporation: Geographical Revenue
Figure 28 Grifols, S.A.: Key Financials
Figure 29 Grifols, S.A.: Segmental Revenue
Figure 30 Grifols, S.A.: Geographical Revenue
Figure 31 Japan Blood Products Organization: Key Financials
Figure 32 Japan Blood Products Organization: Segmental Revenue
Figure 33 Japan Blood Products Organization: Geographical Revenue
Figure 34 Dentsply Sirona: Key Financials
Figure 35 Dentsply Sirona: Segmental Revenue
Figure 36 Dentsply Sirona: Geographical Revenue
Figure 37 Kedrion S.P.A: Key Financials
Figure 38 Kedrion S.P.A: Segmental Revenue
Figure 39 Kedrion S.P.A: Geographical Revenue
Figure 40 LFB Group: Key Financials
Figure 41 LFB Group: Segmental Revenue
Figure 42 LFB Group: Geographical Revenue
Figure 43 Octapharma AG: Key Financials
Figure 44 Octapharma AG:Segmental Revenue
Figure 45 Octapharma AG: Geographical Revenue
Figure 46 Sanquin: Key Financials
Figure 47 Sanquin: Segmental Revenue
Figure 48 Sanquin: Geographical Revenue
Figure 49 Shanghai RAAS: Key Financials
Figure 50 Shanghai RAAS: Segmental Revenue
Figure 51 Shanghai RAAS: Geographical Revenue
Figure 52 Shire: Key Financials
Figure 53 Shire: Segmental Revenue
Figure 54 Shire: Geographical Revenue
+1 888 709 8757
Chat With Us